Concepedia

Magda Chmelikova

MC

3

Publications

863

Citations

3

H-Index

2015

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Stanford University

Fondazione IRCCS Istituto Neurologico Carlo Besta

Magda Chmelikova is an author at Alexion Pharmaceuticals (United States) specializing in medicine, autoimmunity, and autoantibodies.

Top concepts

Publications per year

2015–2020

3

Publications

3

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Anti-Gal IgM, IgA and IgG natural antibodies in childhood

Markéta Hamanová, Magda Chmelikova, Ivo Nentwich et al. · Immunology Letters · 2015 · 44 citations

, , +5

Rows per page

1–3 of 3